AZD9592
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AZD9592, covering 2025-01-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: First in Human Study of AZD9592 in Solid Tumors [Phase 1]